2
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Fentiazac in rheumatoid arthritis: A multicentre study

Pages 64-70 | Accepted 19 Jan 1979, Published online: 21 Aug 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

R. A. Franklin, R. Norris, N. W. Shepherd & S. T. Rhenius. (1984) Preliminary studies on the fate of 14C-fentiazac in man. Xenobiotica 14:12, pages 955-960.
Read now

Articles from other publishers (4)

Manjit Singh, Vijay B. Yadav, Mohd Danish Ansari, Manisha Malviya & I. R. Siddiqui. (2021) Efficient one-pot synthesis of substituted diphenyl 1, 3-thiazole through multicomponent reaction by using green and efficient Iron-catalyst via Cross-Dehydrogenative Coupling(CDC). Molecular Diversity 26:2, pages 843-848.
Crossref
Alok Mahata, Prabhas Bhaumick, Anoop Kumar Panday, Rahul Yadav, Tasneem Parvin & Lokman H. Choudhury. (2020) Multicomponent synthesis of diphenyl-1,3-thiazole-barbituric acid hybrids and their fluorescence property studies. New Journal of Chemistry 44:12, pages 4798-4811.
Crossref
N. Thumb. 1983. Rheumatologie A. Rheumatologie A 335 485 .
L Nespoli, S Guarnaccia, M G Botta, E Adamo & S Bodini. (2016) Clinical Controlled Study of Fentiazac Compared with Placebo in Septic-Inflammatory Pathology of Children's Diseases. Journal of International Medical Research 10:3, pages 183-188.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.